Market Research Report
Digital Pathology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025
|Published by||IMARC Services Private Limited||Product code||930508|
|Published||Content info||109 Pages
Delivery time: 2-3 business days
|Digital Pathology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025|
|Published: March 12, 2020||Content info: 109 Pages||
The global digital pathology market was worth US$ 520.6 Million in 2019. Digital pathology (DP) is a dynamic and image-based system that facilitates acquisition, management and interpretation of information related to human and animal pathology. It processes digital data through scanners, information management systems, storage devices, visualizing software and web and cloud-based communication systems. The DP systems analyze high-resolution samples and store digital slides on a server or the cloud. This enables the pathologists to cross-examine slides in the absence of physical evidence. They also aid in minimizing costs and improving the accuracy of the test results. Consequently, they find extensive application in teleconsultation, disease diagnosis and drug discovery across the educational, medical and pharmaceutical industries.
The rising trend of digitization, along with the increasing adoption of telepathology across the globe, is one of the key factors driving the growth of the market. Telepathology aids in faster and efficient disease diagnosis and ease in consultation, owing to which it is rapidly being incorporated across various healthcare and diagnostic centers. Furthermore, the rising prevalence of chronic medical ailments, such as cancer, is also providing a boost to the market growth. Additionally, various technological advancements, including the integration of Laboratory Information Systems (LIS) and the introduction of digital imaging, robotic light microscopy and multiple fiber-optic communications, are impacting the market positively. Other factors, including rising geriatric population and extensive research and development (R&D) activities in the pharmaceutical and bioscience sectors, are projected to drive the market further. Looking forward, IMARC Group expects the market to reach a value of US$ 984.4 Million by 2025, registering a CAGR of 11.2 % during 2020-2025.
The report has also analysed the competitive landscape of the market with some of the key players being 3DHISTECH, Apollo Enterprise Imaging, Corista, Hamamatsu Photonics, Huron Digital Pathology, Indica Labs, Koninklijke Philips, Leica Biosystems, Objective Pathology Services, Ventana Medical Systems, Visiopharm, XIFIN, etc.